The rise of Viagra initially fueled a boom for major pharmaceutical companies, however recent shifts present a complicated picture for shareholders. Generic competitors are eating into profits, and ongoing patent https://janeuiwh491436.bloggerchest.com/41314528/the-blue-pill-and-pharma-a-risky-play